Abstract: Although class A type I/II scavenger receptor (SR-A) is involved in numerous macrophage functions, its signaling ability remains uncertain. We used monoclonal antibodies (mAb) to specifically stimulate receptors on mouse alveolar (AMs) and peritoneal macrophages (PMs). Immobilized anti
INTRODUCTION
Type I and II class A scavenger receptors are splice variants of a single gene product (referred to herein as scavenger receptor A 1-2 , SR-A). These SR-As are homotrimeric, helically coiled, integral membrane glycoproteins, containing SR cysteine-rich (missing in SR-A 2 ) and collagenous domains in their extracellular portions [1, 2] . SR-A is expressed predominately on macrophages and dendritic cells [3, 4] , furnishing these cells with the ability to bind a multiplicity of polyanionic ligands, including certain native, denatured, or covalently modified proteins, proteoglycans, polynucleotides, acidic phospholipids, sulfatides, sulfated polysaccharides, and bacterial components, such as lipopolysaccharide (LPS) and lipoteichoic acid [5] [6] [7] . Thanks to its extraordinary broad ligand-binding capacity, SR-A may participate in numerous macrophage functions. SR-A has been implicated in endocytosis of covalently modified proteins [8, 9] , in opsonin-independent phagocytosis of bacteria [6, 10 -12] and apoptotic cells [13] , as well as in the clearance of anionic environmental particles from the lung [14] and LPS from the circulation [15, 16] . SR-A is also involved in intercellular cooperation during antigen presentation [4] and in macrophage adhesion to the components of extracellular matrix [3, 7, 17, 18 ] to other cells [19] and to tissue-culture plasticadsorbed serum [20] .
Since the identification of SR-A in 1979 [21] and subsequent cloning in 1990 [1, 2] , signaling by SR-A has been investigated in several studies motivated by demonstration of its role in innate immunity as well as in pathogenesis of atherosclerosis, Alzheimer's disease, and diabetes-associated pathologies [8, 17, 22] . However, although different effects of SR-A ligands on macrophage signaling functions have been reported [23] [24] [25] [26] [27] , the nonselectivity of the ligands used in most studies precludes certainty as to which particular receptor(s) mediate any of the reported effects. Indeed, many of polyanionic ligands bind to numerous other SRs, within class A (e.g., MARCO) or other subclasses [e.g., LOX-1; refs. 28, 29] . In some reports, acetylated low density lipoprotein (AcLDL) and malonaldehyde-modified LDL, prototypes of the SR-A-dependent ligands [8, 30, 31] , seemed neither to trigger any second messenger activity nor to initiate functional or gene effects upon binding to their preferred receptor on macrophages [15, 32] . For instance, SR-A-inhibiting concentrations of AcLDL could not induce tumor necrosis factor ␣ (TNF-␣) production, trigger mobilization of arachidonic acid, or alter LPS stimulation of TNF-␣ release [15] .
In an alternative approach, attempts have been made to deduce SR-A-mediated effects by comparing responses between wild-type and SR-A-deficient macrophages. In general, the results suggest that SR-A-mediated phagocytosis or adhesion is not accompanied by proinflammatory or microbicidal activation of macrophages. For example, although nonopsonic phagocytosis of Neisseria meningitidis was dramatically decreased in bone marrow-derived macrophages from SR-Adeficient mice, TNF-␣, interleukin (IL)-6, IL-10, and IL-12 levels stimulated by these bacteria were not significantly altered [12] . Similarly, SR-A was reported primarily responsible for the adhesion of macrophages to oxidized LDL-coated surfaces but not for hydrogen peroxide (H 2 O 2 ) production under these conditions [33] . In contrast, it has been suggested that SR-A-mediated adhesion of rodent microglia and human monocytes to ␤-amyloid fibril-coated surfaces stimulates secretion of reactive oxygen species [22] .
To more precisely dissect SR-A-specific signaling, we have used the anti-SR-A-specific monoclonal antibody (mAb) 2F8 to selectively stimulate mouse macrophages. The data provide a novel demonstration of signaling by SR-A and suggest a potential role for SR-A in modulation of macrophage cytokine responses.
MATERIALS AND METHODS

Antibodies
Low endotoxin/azide-free, rat anti-mouse CD16/32 (Fc␥R II/III clone 2.4G2), anti-CD44 (clone IM7), and irrelevant rat IgG2b (clone A95-1) mAb were obtained from PharMingen (San Diego, CA). Purified (in part of experiments with immobilized mAb) or low endotoxin/azide-free (when used as soluble) rat anti-mouse SR-A 2F8 mAb was purchased from Serotec (Oxford, UK). ImmunoPure goat anti-rat IgG Fc-specific antibody was purchased from Pierce (Rockford, IL) and fluorescein isothiocyanate (FITC)-conjugated F(abЈ) 2 fragments of goat anti-rat IgG (H and L) antibody, from Rockland Immunochemicals (Golbertsville, PA). All chemical reagents not otherwise specified were obtained from Sigma Chemical Co. (St. Louis, MO).
Animals
Female mice, 9 -14 weeks old, were used in the experiments. SR-A-deficient mice on the C57BL/6 background [8] were maintained in our facility under pathogen-free conditions. C57BL/6 and BALB/c mice were purchased from Charles River Laboratories (Wilmington, MA), C3H/HeJ mice (LPS-nonresponsive strain), from Jackson Laboratories (Bar Harbor, ME), and mice deficient in the ␥ chain of FcRs on BALB/c background, from Taconic (Germantown, NY).
Cell isolation
For bronchoalveolar lavage (BAL), mice were killed by intraperitoneal (i.p.) injection with 0.25-0.3 ml pentobarbital (Fatal-Plus, Vortech Pharmaceuticals, Dearborn, MI), and BAL was performed with phosphate-buffered saline (PBS; pH 7.4, BioWhittaker, Walkersville, MD) at room temperature. BAL cells were collected into centrifuge tubes kept on ice, and after centrifugation, resuspended in Hanks' balanced salt solution (HBSS), serum-free medium (Macrophage-SFM; Gibco, Grand Island, NY) or serum-containing medium [RPMI-1640 medium with 25 mM HEPES (Sigma), supplemented with 10% fetal calf serum (FCS; Gemini Bio-Products, Woodland, CA), 2 mM L-glutamine, and a mixture of 0.1 mg/ml streptomycin and 100 U/ml penicillin, FCS-RPMI]. Alveolar macrophages (AMs) constituted at least 99% of BAL cells, as determined by analysis of Giemsa-Wright-stained cytospine preparations. They were cultured at 3 ϫ 10 5 /ml in 0.1 ml HEPES or 0.16 -0.2 ml FCS-RPMI.
For peritoneal lavage, mice were quickly killed by inhalation of halothane (Halocarbon Laboratories, River Edge, NJ). Resident peritoneal cells or cells elicited with 1 ml aged, 3% thioglycollate (Difco, Detroit, MI), injected i.p. 5 days earlier, were washed out with PBS and after washing once with PBS, were further processed similarly as BAL cells. Peritoneal cells were cultured at 8 -10 ϫ 10 5 /ml.
Receptor cross-linking with immobilized mAb
The antibodies we used against macrophage receptors were generated in the rat and therefore do not bind avidly to protein G. Hence, they were linked to protein G-coated surfaces through a goat antibody, specific for For pertussis toxin (PTX) treatment, AMs were suspended in Macrophage-SFM and incubated in 24-well ultra-low attachment polystyrene plates with 1 g/ml PTX for 4 h at 37°C in a cell culture incubator. Cells were then collected, spun down, resuspended in PTX-containing HBSS, and used in the H 2 O 2 assay.
Release of TNF-␣, IL-6, IL-12 p70, and nitric oxide (NO)
Nitrite, TNF-␣, IL-6, and IL-12 p70 concentrations were determined in supernatants from 20 h cultures of nonadherent cells or tissue-culture plasticadherent macrophages, stimulated as described above with immobilized or soluble mAb.
Nitrite concentrations in 90 l aliquots of culture supernatants were determined according to the Griess method. The sensitivity of the method was increased by dissolving sulfonamide in 2 M HCl instead of orthophosphoric acid and by adding individual reagents sequentially [50 l 1% sulfanilamide, followed by 50 l 0.1% N-(1-naphthyl)ethylenediamine in deionized water], without premixing. Nitrite concentrations in samples were read from standard curves, generated from serial dilutions of NaNO 2 . The detection limit of the assay was 0.1-0.2 M.
IL-6 concentrations in culture supernatants were determined with a sandwich enzyme-linked immunosorbent assay (ELISA) with the use of rat antimouse IL-6 mAb MP5-20F3 and biotinylated rat anti-mouse IL-6 mAb MP5-32C11 (PharMingen) as the capture and detecting antibody, respectively. HRP-streptavidin conjugate was obtained from Vector Laboratories (Burlingame, CA), murine IL-6 standard, from PharMingen, and MaxiSorp ELISA plates, from Nunc (Rochester, NY).
IL-12 p70 and TNF-␣ determinations were performed with the use of mouse IL-12 p70 or TNF-␣ duo set ELISA kits from R&D Systems, according to the manufacturer's instructions.
Effects of H 2 O 2 donors or scavengers
Macrophages were loaded with glutathione (GSH) by 3 h incubation with 20 mM GSH monoethyl ester (Calbiochem, San Diego, CA) in FCS-RPMI medium. After washing once with HBSS or FCS-RPMI medium, they were used in the H 2 O 2 or cytokine/NO assays, respectively. In other experiments, H 2 O 2 was scavenged by inclusion of 10 kU/ml catalase in the culture medium. Adherent, thioglycollate-elicited peritoneal macrophages (PMs) were preincubated for 1 h with 20 or 50 ng/ml H 2 O 2 -generating glucose oxidase, and after washing once, they were stimulated with LPS and IFN-␥ in FCS-RPMI medium.
Cell viability
Viability of freshly isolated cells was routinely assessed by their ability to exclude trypan blue. According to this criterion, Ն95% of BAL or thioglycollate-elicited peritoneal cells and essentially all resident peritoneal cells were viable. The effect of treatments on macrophage viability was assessed by measuring lactic dehydrogenase (LDH) release from the cells (Cytotoxicity Detection kit, Roche Diagnostics, Mannheim, Germany), according to the manufacturer's instructions. In brief, the percent cytotoxicity was calculated as the ratio of LDH in culture supernatants to the total LDH (cell-associated plus that in supernatant) ϫ 100%. Twenty hours treatment with LPS and IFN-␥ caused minor cytotoxicity to macrophages, decreasing their viability from 93-90% (ϳ3% cytotoxicity attributable to LPS/IFN-␥ treatment). Neither 2F8 nor isotype-matched mAb had any effect on cell viability (data not shown).
Adhesion assay
Divalent cation-independent adhesion of cells to immobilized antibodies was determined at the end of the H 2 O 2 assay. The wells were supplemented with 0.1 ml RPMI-1640 medium, containing 20 mM EDTA (final concentration, 10 mM), and were incubated for a further 25 min at 37°C in a cell-culture incubator. After washing three times with PBS, adherent cells were solubilized with 0.1% Triton X-100 in PBS, and LDH activities in cell lysates were determined with the use of a cytotoxicity detection kit (LDH). Total LDH activity of plated cells was determined in parallel and used to calculate percentage of adherent cells. Pilot studies showed a linear correlation between cell number and LDH values (R 2 ϭ0.9998) and high sensitivity of the LDH assay (ϳ60 AMs/well for the 30Ј time of enzymatic reaction per usual protocol).
Flow cytometric analysis of receptor expression
Cells (ϳ5ϫ10 6 ) were incubated for 30Ј with 10 g/ml receptor-specific or isotype-matched, control mAb in 0.4 ml ice-cold FACS buffer (0.1% NaN 3 and 2% FCS in PBS). Subsequently, 2 ml FACS buffer was added, cells were spun down, washed once again, and resuspend in 0.4 ml 50 g/ml FITC-labeled F(abЈ) 2 of goat anti-rat IgG for 30Ј incubation on ice. After washing two times, receptor expression was analyzed in the Epics Elite flow cytometer (Coulter, Fullerton, CA).
Statistical analysis
After assessing homogeneity of variances with an F test, means were compared with Student's t-test for single comparison or ANOVA for multiple comparisons, with the assumption that P values Ͻ0.05 indicate statistically significant differences (GraphPad Prism software, San Diego, CA).
RESULTS
Ligation of SR-A or Fc␥RII/III with immobilized mAb stimulates H 2 O 2 production in macrophages
AMs from C3H/HeJ mice, stimulated for 40Ј with immobilized anti-SR-A 2F8 or anti-Fc␥RII/III 2.4G2 mAb, released, re- spectively, 1.55 Ϯ 0.08-and 1.98 Ϯ 0.135-fold more H 2 O 2 than cells plated in wells coated with isotype-matched, nonimmune rat IgG2b (Figs. 1A and 2A) . Both 2F8 and 2.4G2 mAb also stimulated H 2 O 2 production significantly in resident peritoneal cells from C3H/HeJ mice (1.66Ϯ0.135-and 2.28Ϯ0.085-fold, respectively, nϭ3, data not shown). Enhancement of fluorescence caused by 2F8 mAb-stimulated H 2 O 2 production was first observed after 10 -15 min of the assay (Fig. 1) and reached a plateau at ϳ60 min, likely reflecting cessation of respiratory burst (data not shown). The 2.4G2-stimulated respiratory burst was more rapid (e.g., detected after 5 min) and somewhat larger but reached a plateau earlier, at ϳ40 min (Fig. 1) .
The effect of 2F8 mAb on H 2 O 2 production resulted specifically from ligation of SR-A because it occurred neither in AMs from SR-A-deficient nor C56BL/6 mice (Figs. 1B and 2A) The specificity of receptor ligation by immobilized mAb was also confirmed in the adhesion assay. Immobilized 2F8 mAb enhanced divalent cation-independent adhesion of C3H/HeJ, BALB/c, and Fc␥RI/IIIϪ/Ϫ AMs but did not have any effect on C57BL/6 or SR-AϪ/Ϫ AMs (which do not bear epitopes recognized by 2F8). In contrast (and as a further control for these adhesion assays), 2.4G2 mAb supported adhesion of AMs from all strains that express the Fc␥RII/III antigen (C3H/HeJ, BALB/c, SR-AϪ/Ϫ, and C57BL/6) but had no specific effect on adhesion by Fc␥RI/IIIϪ/Ϫ AMs (Fig. 2B ).
PTX inhibits SR-A-but not Fc␥RIII-stimulated respiratory burst
Involvement of PTX-sensitive heterotrimeric G proteins (G i/o ) in SR-A signaling has been reported [37, 38] . Pretreatment with PTX (1 g/ml for 4 h) decreased H 2 O 2 production stimulated by 2F8 mAb and by "nonspecific" adhesion to wells not coated with mAb but not that stimulated by 2.4G2 mAb (Fig.  3A) . In the average from four experiments, PTX decreased SR-A-mediated stimulation of H 2 O 2 production by 75.4 Ϯ 5.86% (Pϭ0.001), whereas that mediated by Fc␥RIII was not significantly affected (Fig. 3B ).
Ligation of SR-A selectively inhibits IL-12 release
The effect of receptor cross-linking with immobilized mAb on IL-6, TNF-␣, and IL-12 p70 release from C3H/HeJ AMs was studied during 20 h incubation in serum-free medium. Cells cultured in wells coated with control IgG2b released similar quantities of IL-6 (21-103 pg/ml) and TNF-␣ (0.9 -1.4 ng/ml) as those plated in wells coated with 2F8 or 2.4G2 mAb (data 
-test). (B)
. EDTA-resistant adhesion of AMs to plates coated with mAb. At the end of the H 2 O 2 assay, EDTA-resistant adhesion to 2F8 or 2.4G2 mAb was determined and expressed as percent of adherent cells over the levels of isotype-matched IgG2b controls (the latter ranging from ϳ8% of plated cells for Fc␥RI/IIIϪ/Ϫ AMs to ϳ35% for SR-AϪ/Ϫ AMs). not shown). AM adhesion to plates coated only with protein G stimulated IL-12 p70 release (80 -180 pg/ml) to an extent similar as that stimulated by LPS ϩ IFN-␥ treatment in LPSnormoresponsive AMs (see below), whereas IL-12 release from AMs adhering to uncoated plates was undetectable. Interestingly, the unexpected IL-12 production caused by protein G-only-coated plates was selectively inhibited in the presence of immobilized 2F8 (by 16Ϯ2.8%, Pϭ0.03, nϭ3) but not 2.4G2 or control IgG2b mAb (data not shown).
To determine whether ligation of SR-A inhibits IL-12 release stimulated by the classic activators LPS and IFN-␥, nonadherent AMs were stimulated with LPS/IFN-␥ in the presence of soluble 2F8 or control IgG2b mAb. Ligation of SR-A on AMs from BALB/c mice with 2F8 mAb (20 g/ml) caused 25 Ϯ 4.6% inhibition (Pϭ0.001, nϭ8) of IFN-␥ (20 ng/ml) plus LPS (1 g/ml)-stimulated IL-12 p70 release (Fig.  4, A and B) . In AMs from C57BL/6 mice, 2F8 mAb did not inhibit IL-12 release (Fig. 4B) , demonstrating the SR-A specificity of this response. In contrast to effects on IL-12, neither 2F8 nor isotype-matched, control mAb affected LPS plus IFN-␥-stimulated IL-6 accumulation in the cultures of AMs (Fig. 4 , C and D). Also LPS plus IFN-␥-stimulated nitrite accumulation in C57BL/6 or BALB/c AM cultures was not affected by any of these mAb (data not shown).
Magnitude of 2F8 mAb effect reflects levels of SR-A expression
We hypothesized that the relatively modest effect of 2F8 mAb, ϳ25% on both H 2 O 2 ( Fig. 2A) and IL-12 ( Fig. 4B ) release in BALB/c AMs, is linked to a relatively modest level of SR-A expression on normal mouse AMs. This assumption was confirmed by flow cytometric analysis, showing low (as compared with anti-CD44 mAb), uniform labeling of BALB/c AMs with 2F8 mAb [specific mean fluorescence intensity (MFI)ϭ1.6, Fig. 5A ]. To identify a macrophage population with higher SR-A expression, we examined SR-A levels on thioglycollateelicited PMs. Inflammatory PMs in the fifth day after thioglycollate injection consisted of two distinct, roughly equal-sized populations: Small, monocyte-like cells exhibited very weak expression of SR-A (specific MFIϭ0.1), whereas expression of SR-A on large macrophages filled with endocytotized material was much higher (specific MFIϭ9.1) than on AMs (Fig. 5B) . Consistent with our hypothesis, in this mixed population of thioglycollate-elicited peritoneal cells, 2F8 mAb tended to produce stronger inhibition of IL-12 release than in AMs, by 39 Ϯ 11.3% (nϭ3; Fig. 4B) . The difference between inhibition seen in AMs (nϭ8) and the inhibition seen in peritoneal cells (nϭ3) was not statistically significant per se (Pϭ0.1). However, if one outlier out of eight experiments performed on AMs (52% as compared with 11-25% inhibition in the remaining experiments) is excluded, the difference is statistically significant (Pϭ0.013). Even stronger inhibition of IL-12 release was produced by 2F8 mAb in inflammatory PMs, which were purified by overnight adhesion to tissue-culture plastic: 68 Ϯ 4.5% as compared with only 25 Ϯ 1.6% inhibition in similarly treated AMs (Pϭ0.01, nϭ2, Fig. 4B ).
In resident peritoneal cells from BALB/c mice, treatment with LPS and IFN-␥ did not stimulate detectable release of IL-12 p70, and therefore, the effect of 2F8 mAb could not be examined, whereas IL-6 release was not affected by 2F8 or nonimmune IgG2b mAb (data not shown).
H 2 O 2 does not seem to mediate inhibition of IL-12 release caused by SR-A ligation
To determine whether SR-A-stimulated H 2 O 2 is involved in the inhibition of IL-12 release, catalase was included during stimulation of adherent, inflammatory PMs. As H 2 O 2 is a membrane-diffusible molecule, scavenging of extracellular H 2 O 2 by catalase should also decrease its intracellular concentration. Indeed, in rat AMs, exogenous catalase at 200 U/ml almost completely abrogated zymosan-activated serum-stimulated, H 2 O 2 -mediated tyrosine phosphorylation and activation of extracellular signal-regulated kinase 1/2 [39] . In contrast, exogenous catalase did not affect the 2F8 mAb-mediated inhibition of IL-12 release, even at concentration as high as 10,000 U/ml (Fig. 6A) . The catalase added was validated as biologically active by its inhibition of the increase in H 2 O 2 detected by the Amplex Red assay (as in Fig. 1, data not shown) . Moreover, 2F8 mAb-mediated inhibition of IL-12 release was not mimicked by H 2 O 2 released by 20 ng/ml or 50 ng/ml glucose oxidase (Fig. 6B) . Glucose oxidase at 20 ng/ml released H 2 O 2 with a rate similar to 2F8 mAb-stimulated AMs (data not shown).
Reduced GSH, cooperating with GSH peroxidase and reductase, constitutes the major antioxidant system of macrophages [40] , which by reducing H 2 O 2 -oxidized cysteine residues in proteins, is also involved in the termination of H 2 O 2 signaling [41] . In adherent, inflammatory PMs, preincubated for 3 h with a 20-mM membrane-permeable form of GSH, 2F8 mAb-stimulated H 2 O 2 release was completely inhibited (Fig. 6C) . Although consistent with previous reports [42] , cells preincubated with GSH also released much more IL-12 upon LPS/ IFN-␥ stimulation, the degree of SR-A-mediated inhibition of IL-12 release was not affected (Fig. 6D) . Taken together, the above results do not support a role for H 2 O 2 in mediating inhibition of IL-12 release upon SR-A ligation.
DISCUSSION
We observed that following ligation with 2F8 mAb, SR-A on mouse macrophages mediates H 2 O 2 production and inhibition of IL-12 release. Responses to 2F8 mAb resulted specifically from ligation of SR-A rather than Fc␥Rs, as evidenced by their lack in C57BL/6 and SR-A-deficient mice and occurrence in Fc␥RI-and III-deficient mice. The lack of 2F8 mAb effects in C57BL/6 and SR-AϪ/Ϫ AMs and conversely, their demonstration in LPS-nonresponsive C3H/HeJ AMs also rule out a significant contribution of contaminating endotoxin. Finally, the magnitude of 2F8 mAb-triggered responses correlated with the level of SR-A expression, as determined by flow cytometric analysis and adhesion of cells to antibody-coated surfaces.
The question of whether SR-A-mediated signaling requires receptor cross-linking has not been addressed directly by the present study. Nevertheless, two observations suggest that extensive cross-linking may not be required. First, we obtained the responses reported using (merely) divalent mAb, and second, AM H 2 O 2 production was stimulated to a similar degree by surface-immobilized (and therefore, possibly causing more cross-linking) 2F8 mAb and soluble antibody (data not shown).
Three types of methodological approaches have been applied to studies of SR-A signaling. These include studying effects of nonselective SR ligands on macrophages [15, 24, 26, 27, 32] or on cell lines transfected with SR-A [27, 38] . In the third approach, attempts have been made to deduce SR-Amediated effects by comparing responses to such ligands between wild-type and SR-A-deficient macrophages [12, 33] . With one exception [38] , these methods do not allow drawing definite conclusions about signaling abilities of SR-A. For instance, Peiser et al. [12] found no significant differences in cytokine (including IL-12) responses to N. meningitidis between wild-type and SR-AϪ/Ϫ macrophages. However, SR-A deficiency may be accompanied by compensatory changes in other receptor systems involved in bacteria recognition. Conversely, transfected cells may respond differently than macrophages or be unable to generate macrophage-like responses. Moreover, the ligands may activate endogenous receptors in transfected cells. A good illustration of problems encountered when using transfected cells is the study by Hsu et al. [27] . The authors reported stimulation of phosphorylation of unidentified One major technical obstacle is that nonselective ligands used in studies on SR-A signaling in macrophages may activate a broader range of macrophage SRs [28 -30, 43-45] as well as receptors not classified into the artificial family of SRs [46, 47] . Modified LDLs may also be a source of lipid mediators acting through yet another set of receptors [48] . Finally, macrophages are known to respond to even trace endotoxin contamination [49] , whereas such contamination of ligands used to analyze SR-A was present [47, 50] or not reported [24, 26, 27, 51] . Sutterwala et al. [52] reported that mal-BSA-coated erythrocytes inhibited the induction of IL-12 by LPS or LPS ϩ IFN-␥ in murine macrophages. The authors reported that SR-A selectivity of mal-BSA-coated erythrocytes had been confirmed by inhibiting their binding to macrophages with receptorspecific mAb or competitive ligands, although neither the data nor details were shown. One concern is that mal-BSA is not a selective ligand of SR-A on macrophages, as it also binds to CD36 and SR-BI, a class B SR [30] . At least one of these receptors, CD36, is known to mediate inhibition of IL-12 release [53] . Conversely, activation of macrophages by mal-BSA seems mediated by low-affinity receptors, distinct from high-affinity "AcLDL receptor" (SR-A) [32] . Similarly, in the reported promotion of Th1-type responses by maleylated antigens, receptors other than SR-A seem to participate, since these responses occurred also when B cells, which do not express SR-A, were used as antigen-presenting cells [54] .
The use of receptor-specific antibody allowed us to avoid the problems associated with nonspecific, polyanionic SR ligands. However, this approach introduces its own potential specificity issues: effects via FcR ligation and effects from unexpected cross-reactivity with other surface receptors. The former was addressed by use of isotype control IgG, as well as studies in Fc␥R-deficient macrophages. The demonstration of lack of response in SR-A-deficient mice and in a strain, which expresses an allelic form of SR-A that does not react with the 2F8 mAb, allows exclusion of unexpected cross-reactivity.
PTX has been reported to decrease by 46% SR-A-mediated uptake of AcLDL in mouse peritoneal macrophages [37] or in human embryonic kidney cells transfected with murine SR-A 2 [38] and by 37% SR-A-mediated adhesion of transfected cells, with accompanying attenuation of focal adhesion complex formation [38] . Our results confirmed involvement of PTX-sensitive G i/o proteins in signaling by SR-A in mouse AMs. Pretreatment with PTX inhibited by ϳ75% respiratory burst stimulated in C3H/HeJ AMs by immobilized 2F8 mAb. The mode of SR-A coupling to G protein(s) remains unknown. Extracellular cooperation with some other G protein-coupling receptor(s) is a possibility, as SR-A-mediated cell adhesion and spreading were inhibited by PTX [38] but not by deletion of an almost entire cytoplasmatic domain of SR-A [55] . H 2 O 2 can act as a second messenger in intracellular signaling. The best-characterized pathways include direct activation of protein kinase C by H 2 O 2 , and H 2 O 2 -mediated inhibition of specific phosphatases, which enable signaling through protein tyrosine kinases and phosphatidylinositol 3-kinase [56] . Activation of some of these pathways is known to inhibit IL-12 production in immune cells [39, 42, 57] . Nevertheless, our results do not support a mechanistic or causal role for H 2 O 2 in the inhibition of IL-12 release in response to SR-A ligation. The inhibition was neither reversed by high concentrations of exogenous catalase nor mimicked by glucose oxidase-derived H 2 O 2 . Moreover, loading of macrophages with GSH and completely inhibiting SR-A-stimulated H 2 O 2 release had no effect on SR-A-mediated inhibition of IL-12 release.
The in vivo biological significance of the two macrophage responses identified in our studies remains to be determined. Our data do indicate the feasibility of using mAb assure specificity and to avoid problems inherent in ligation of SRs with potentially polyspecific ligands. Future studies using this antibody-based approach and array analysis approaches may provide additional insights into the signaling and functional consequences of SR-A ligation.
